News from islet sciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 23, 2014, 08:00 ET

Islet Sciences, Inc. Highlights Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)

 Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing new medicines and technologies for the treatment and diagnosis...

Jun 18, 2014, 08:00 ET

Islet Sciences, Inc. to Present at the Joint Meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014

 Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing new medicines and technologies for the treatment and diagnosis...

Jun 16, 2014, 08:00 ET

Islet Sciences, Inc. Presents Positive Clinical Results for Best-in-Class SGLT2 Inhibitor at American Diabetes Association (ADA) Annual Meeting

 Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing new medicines and technologies for the treatment and diagnosis...

Jun 12, 2014, 08:00 ET

Islet Sciences, Inc. to Present at American Diabetes Association (ADA)

 Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing novel technologies for the treatment and diagnosis of...

May 29, 2014, 07:57 ET

Islet Sciences, Inc. Appoints Steven Delmar as Chief Financial Officer

 Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing novel technologies for the diagnosis and treatment of...

Jun 27, 2013, 15:21 ET

Islet Sciences Chief Scientific Officer Receives $1.27 million in Grant from JDRF to Create Innovative Diabetes Treatments

Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies...

Jun 24, 2013, 07:55 ET

Islet Sciences, Inc. Technologies Featured in Five Separate Presentations at the American Diabetes Association Annual Meeting

 Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented...

Jan 08, 2013, 10:52 ET

Islet Sciences Announces Inclusion in BioWorld Today Article

 Islet Sciences, Inc., (OTC Bulletin Board: ISLT) a clinical stage company engaged in the research, development and commercialization of...

Oct 11, 2012, 16:12 ET

Islet Sciences Announces Publishing of Study Results of Production and Function of IL-12 in Islets and Beta Cells in Diabetologia

 Islet Sciences, Inc., (OTCBB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented...

Sep 12, 2012, 11:00 ET

Islet Sciences Announces Exclusive License Agreement with the University of California (UCLA) to Commercialize Small Molecules for Islet Expansion

 Islet Sciences, Inc., (OTCBB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented...

Sep 10, 2012, 08:30 ET

Islet Sciences Announces Exclusive License Agreement with Winthrop University Hospital to Commercialize a Beta Cell Loss Measurement Technology in Diabetes

 Islet Sciences, Inc., (OTCBB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented...

Sep 06, 2012, 08:30 ET

Islet Sciences Appoints Dr. Kevan Herold and Dr. Morton Printz to Scientific Advisory Board

Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies in...

Sep 04, 2012, 13:12 ET

Islet Sciences Names Richard A. Franco, Sr. to its Board of Directors

Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies in...

Aug 07, 2012, 16:04 ET

Islet Sciences Announces Strategic Alliance with Spring Point Project

 Islet Sciences, Inc., (OTCBB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented...

Jun 04, 2012, 08:45 ET

Islet Sciences Announces Participation at the 2012 American Transplant Congress

Islet Sciences, Inc., (OTCBB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies in...

May 07, 2012, 13:48 ET

Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic

 Islet Sciences, Inc., (OTCBB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented...

Apr 09, 2012, 13:23 ET

Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology

Islet Sciences, Inc., (OTCBB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies in...

Mar 29, 2012, 12:00 ET

Islet Sciences Announces DiaKine Therapeutics' Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection

 Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented...

Mar 27, 2012, 08:00 ET

Islet Sciences Announces Creation of Scientific Advisory Board with Dr. Paul Johnson and Dr. Jonathan Lakey Along with Four Additional Inaugural Members

 Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented...

Mar 23, 2012, 11:54 ET

Islet Sciences Announces Closing of DiaKine Therapeutics Acquisition

Islet Sciences, Inc. (OTC.BB: ISLT), a biotechnology company engaged in the research, development and commercialization of patented technologies in...